Daily Stock List
Dakota Territory Resource Corp. (DTRC)
OTC Markets Group and UltimatePennyStock reported earlier on Dakota Territory Resource Corp. (DTRC), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Dakota Territory Resource Corp.’s emphasis is the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. It maintains 100 percent ownership of three mineral properties. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All are in the heart of the Homestake District and cover a total of roughly 3,057 acres. Dakota Territory Resource lists on the OTCQB. The Company has its headquarters in Reno, Nevada.
The Blind Gold Property is its flagship property. It is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is approximately four miles northwest and on structural trend with the historic Homestake Gold Mine. The Homestake Gold Mine produced approximately 40 million ounces of gold through its 125 year production history. It is the largest iron-formation-hosted gold deposit in the world.
In the 1980's and 1990's Homestake Mining Co. undertook a $70 million exploration program managed by Mr. Richard Bachman, president and Chief Executive Officer of Dakota Territory. The program focused primarily on the search for a repeat of the Homestake Mine. This program successfully discovered significant new gold mineralization beyond the confines of the producing mine. It demonstrated repeatability and the potential for additional gold deposits in the Homestake iron-formation host. In addition, this program proved the continuous extension of the Homestake iron-formation to a distance of approximately four miles from the producing mine and under the Blind Gold Property.
Dakota Territory’s City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek consists of 21 unpatented lode mining claims located one mile northeast of the Homestake Open Cut and one mile northwest of the City of Deadwood. The Company’s Homestake Paleoplacer Property consists of 13 unpatented lode mining claims located one mile north of the Homestake Open Cut.
Last week, Dakota Territory Resource reported historic assay data from core and reverse circulation holes previously drilled by Homestake Mining Company on Dakota Territory's Homestake Paleoplacer Property. Drill Hole CE16 intersected 3 meters of gold mineralization assaying 5.85 grams per tonne in a flat lying quartz-pebble conglomerate of the Deadwood Formation at a depth 164 meters below the surface. Furthermore, drill hole CE12A intersected 2 meters of 8.46 grams per tonne gold also in a quartz-pebble conglomerate at a depth of 192 meters below the surface.
Yesterday, Dakota Territory Resource announced it completed an internal technical analysis of conceptual development plans for the Homestake Paleoplacer Project in the northern Black Hills of South Dakota. The technical analysis took place to develop a complete project schedule, to identify critical path project elements, to optimize surface and underground drill programs, and to test the potential economic viability of a technically successful project.
Dakota Territory Resource Corp. (DTRC), closed Wednesday's trading session at $0.2399, even for the day. The average volume for the last 60 days is 15,366 and the stock's 52-week low/high is $0.0511/$0.70.
Sunvalley Solar, Inc. (SSOL)
Wallstreetlivechat, Fast Moving Stocks, The Stock Scout, PennyStockClub, PennyStocks24, Penny Stock Rumble, and Penny Stock Pros reported earlier on Sunvalley Solar, Inc. (SSOL), and we choose to report on the Company today, here at the QualityStocks Daily Newsletter.
Sunvalley Solar, Inc. is a solar power technology and system integration enterprise headquartered in Los Angeles, California. The Company provides comprehensive solar energy technology, system design, installation, equipments, and technical support for electrical contractors, builders, homeowners, government entities, and businesses/commercial buildings. It provides an all-in-one service for customers' solar system needs. This is from system design and permitting, to installation and final inspection.
Sunvalley Solar is a foremost solar electric equipment wholesale distributor for solar photovoltaic equipment of manufacturers. The Company specializes in packaged solar system solutions. Its focus is Solar System Design and Installation, Solar Equipment Distribution, Solar Technology Research and Development, and as a National Solar Technical Support and Service Center.
Sunvalley Solar growth strategy includes developing and commercializing its proprietary solar technologies. This includes its coating and focusing technologies, racking, and panel cleaning system.
Its growth strategy also includes promoting and enhancing its brand and reputation in solar design and integration and expanding its installation business, and developing a PV panel manufacturing capability to provide high efficiency and low cost solar panels to the U.S. market. In addition, its’ focus is getting involved in the private power providing business (Distributed Power Plants).
The Company’s Research and Development (R&D) team consists of PhDs in Optoelectronics. The team specializes in photovoltaic panel technologies (coating and focusing). Sunvalley Solar’s R&D team’s projects include 975 kW commercial solar power systems for distribution warehouses and manufacturing companies, and 1 MW commercial solar power systems for agriculture farms and cold storage facilities.
Sunvalley Solar announced in June 2014 that it was awarded a new 676.5 KW solar system installation contract for Raven Farms in Selma, California. When completed, the system will generate more than 1.1 million kWh of clean energy to offset 75 percent of the facility's electric bill. The expectation is that the system will pay for itself in roughly four years and lessen the plant's carbon footprint by more than1.6 million pounds of CO2 each year.
Sunvalley Solar, Inc. (SSOL), closed Wednesday's trading session at $0.016, up 11.89%, on 60,410 volume with 7 trades. The average volume for the last 60 days is 86,936 and the stock's 52-week low/high is $0.009/$0.034.
Noble Roman's, Inc. (NROM)
Wall Street Resources and TaglichBrothers reported recently on Noble Roman's, Inc. (NROM), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Incorporated in 1972, Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company has awarded franchise and/or license agreements in all 50 states plus Washington, D.C., Puerto Rico, the Bahamas, Italy, Canada, and the Dominican Republic. Noble Roman's has its corporate headquarters in Indianapolis, Indiana and the Company lists on the OTC Markets’ OTCQB.
Noble Roman's franchises and licenses under the Noble Roman’s Pizza, Noble Roman’s Take-N-Bake, and Tuscano’s Italian Style Subs trade names. These offer pizza and sub sandwiches, and other related menu items. The Company’s focus is on growth in its three primary venues. These are non-traditional franchises/licenses other than grocery stores, the sale of take-n-bake pizzas through grocery deli departments, and stand-alone take-n-bake franchised locations.
Noble Roman’s developed a take-n-bake version of its pizza as an addition to its menu offerings. The design of take-n-bake pizza is as an add-on component for new and existing convenience stores, as a stand-alone offering for grocery stores, and as the centerpiece of Noble Roman’s stand-alone take-n-bake retail outlet concept.
The Company offers the take-n-bake program in grocery stores as a license agreement rather than a franchise agreement. The stand-alone take-n-bake pizza and take-n-bake in convenience stores are offered under a franchise agreement. Moreover, take-n-bake is an available menu offering under presently existing franchise/license agreements in convenience stores.
This past November, Noble Roman's announced that Mr. Paul Mobley assumed the newly created title of Executive Chairman and retained Chief Financial Officer responsibilities. Mr. Scott Mobley assumed the title of Chief Executive Officer in place of his role as Chief Operating Officer. Noble Roman's indicated that it does not anticipate any changes in current strategy at this time because of this change. As of December 31, 2013, Noble Roman's operated 2,029 franchised or licensed outlets.
Noble Roman's, Inc. (NROM), closed Wednesday's trading session at $2.45, up 2.17%, on 65,787 volume with 65 trades. The average volume for the last 60 days is 57,518 and the stock's 52-week low/high is $1.16/$2.40.
Soligenix, Inc. (SNGX)
InvestorPlace reported recently on Soligenix, Inc. (SNGX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Soligenix, Inc. is a late-stage biopharmaceutical company based in Princeton, New Jersey. It is developing products that address unmet medical needs in the areas of inflammation, oncology, and biodefense. Its proprietary vaccine thermostabilization technology is ThermoVax™. Soligenix’s areas of focus include a therapeutics segment devoted to the development of products for orphan diseases and areas of unmet medical need including cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host disease (GVHD).
A second area of focus is a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis. Soligenix is developing proprietary formulations of oral BDP (beclomethasone 17,21-dipropionate) for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation. This includes pediatric Crohn's disease (SGX203) and acute radiation enteritis (SGX201).
Soligenix is also advancing its novel innate defense regulator (IDR) technology SGX942 for the treatment of oral mucositis and SGX301, its novel first-in-class photodynamic technology using synthetic hypericin with safe visible light, for the treatment of cutaneous T-cell lymphoma.
The Company’s biodefense products in development are a recombinant subunit vaccine called RiVax™. The design of it is to protect against the lethal effects of exposure to ricin toxin. Products also include VeloThrax™, a vaccine against anthrax exposure. Additionally, Soligenix is developing OrbeShield™ for the treatment of gastrointestinal acute radiation syndrome (GI ARS) under a BARDA (Biomedical Advanced Research and Development Authority) contract award.
Furthermore, Soligenix has an exclusive global collaboration with Intrexon Corp. (XON). The focus of it is on the joint development of a treatment for Melioidosis, a high priority biothreat and an area of unmet medical need.
Last week, Soligenix announced the publication of data demonstrating enhanced immunogenicity and rapid action of its anthrax vaccine, VeloThrax™. VeloThrax™ utilizes a derivative of recombinant protective antigen, called Dominant Negative Inhibitor (DNI), which is a candidate for inclusion in a next generation anthrax vaccine. The use of Soligenix’s proprietary vaccine stabilization technology, ThermoVax™, has been previously demonstrated to enhance the thermostability of VeloThrax™, allowing distribution without cold chain requirements.
This week, Soligenix announced that it will be presenting preclinical data from two biodefense programs at the upcoming American Society of Microbiology (ASM) Biodefense and Emerging Diseases Research Meeting. This will take place from February 9-11, 2015, at the Washington Marriott Wardman Park, 2660 Woodley Rd. NW.
Soligenix, Inc. (SNGX), closed Wednesday's trading session at $1.25, down 10.71%, on 71,761 volume with 79 trades. The average volume for the last 60 days is 77,794 and the stock's 52-week low/high is $0.91/$2.49.
Vaccinogen, Inc. (VGEN)
Wyatt Investment Research and InvestorPlace reported recently on Vaccinogen, Inc. (VGEN), RedChip and Zacks did earlier, and today we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.
Founded in 2007, Vaccinogen, Inc. is a cancer immunotherapy development company based in Frederick, Maryland. The Company is clinically testing OncoVAX®, a treatment designed to prevent the recurrence of colon cancer and potentially other solid tumors. It is a patented process, which leverages a patient's own live tumor cells to launch an extensive immune response against minimal residual disease. Vaccinogen lists on the OTC Markets’ OTCQB.
The Company believes that OncoVAX®, at an optimum dose and regimen, is the first colon cancer vaccine to demonstrate effectiveness in preventing cancer recurrence following surgical resection through addressing the diversity of cancer cells inherent to each patient's tumor.
Five clinical studies of OncoVAX® have been completed to date. This includes a Phase III trial with the optimum dose and regimen. Vaccinogen expects to start enrolling patients in a pivotal Phase IIIb trial under an FDA Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) within 60 days of obtaining adequate funding.
Vaccinogen has the manufacturing capability to produce OncoVAX® for its pivotal Phase IIIb trial. It also has a strong novel patent portfolio to protect it and the Company’s other platforms. Vaccinogen has developed other programs in both active specific immunotherapy (vaccines) and passive specific immunotherapy (fully human monoclonal antibodies).
In addition, the Company is concentrating on discovering, developing, and manufacturing fully human monoclonal antibodies for human clinical use. Vaccinogen’s HumaSPECT antibody was one of the first to be widely approved for any clinical use globally.
Last week, Vaccinogen announced the closing of the second $10 million tranche of the $80 million financing announced in August 2014. The second tranche brings the total amount closed to $20 million of the $80 million committed at $5.50 per share or unit. The capital will be used to fund further Company expansion and ACTIVE, a confirmatory Phase IIIb study of OncoVAX®.
Vaccinogen, Inc. (VGEN), closed Wednesday's trading session at $3.09, up 6.55%, on 86,625 volume with 81 trades. The average volume for the last 60 days is 8,099 and the stock's 52-week low/high is $1.99/$9.75.
Octagon 88 Resources, Inc. (OCTX)
StreetAuthority Financial, Investors Insights, Flagler Financial Group, The Street, PennyStocks24, and iStockAnalyst reported previously on Octagon 88 Resources, Inc. (OCTX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Incorporated on June 9, 2008, Octagon 88 Resources, Inc. is a development stage oil and gas company that lists on the OTC Market Group’s OTCQB. It has acquired light and conventional heavy oil assets in Northern Alberta. The Company is the largest publicly traded shareholder of CEC North Star Energy Ltd., presently holding 30.7 percent of its shares. Octagon 88 Resources is headquartered in Steinhausen, Switzerland.
The Company’s current program schedule involves working with the operator of the properties, CEC North Star, to bring on production and cash flow through its direct working interests, and indirect investments spread throughout the projects. CEC North Star Energy is a private incorporated entity in the Province of Alberta.
Octagon 88’s initial plan is, via CEC North Star, to drill and develop the Elkton Erosional Edge project. The overall Elkton schedule foresees first oil sales beginning in early 2015 with initial plans for 5 horizontal production wells. The Company hopes to generate revenues through CEC North Star with its planned operations. It has an immediate capital requirement of approximately $1,000,000 to be funded for the drilling of the first well on the Trout Lake property.
Subsequently, Octagon 88 Resources will be required within six months from the successful completion of the well to pay Zentrum $1,250,000 to earn its 50 percent working interest. With the Zentrum credit facility in place, the Company believes that it will have sufficient working capital to fund its continuing administrative operations for the next twelve months.
This past November, Octagon 88 Resources announced that it received confirmation from the Operator that the drill license for the third Elkton well (11-4-92-23W5M) was approved. The Operator planned to spud the Elkton well before December 31, 2014. Moreover, the Operator plans to go ahead with drilling a vertical well to obtain additional core information, which will define an Enhanced Oil Recovery (EOR) method to be implemented on the horizontal well to follow.
Octagon 88 Resources, Inc. (OCTX), closed Wednesday's trading session at $0.4001, down 33.32%, on 15,500 volume with 9 trades. The average volume for the last 60 days is 9,127 and the stock's 52-week low/high is $0.40/$6.15.
CNS Response, Inc. (CNSO)
RedChip and PennyStocks24 reported recently on CNS Response, Inc. (CNSO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
CNS Response, Inc. is a neuroscience company based in Aliso Viejo, California. The Company focuses on improving the quality of treatment for patients with brain disorders, through providing objective information to prescribers. Its’ Psychiatric EEG Evaluation Registry (PEER Online), is a cloud-based platform. It permits physicians to exchange outcome data referenced to their patients' neurophysiology. CNS Response’s shares trade on the OTC Markets’ OTCQB.
The Company provides a unique set of reference data and analytic tools for clinicians and researchers in psychiatry. Its PEER Online is a new registry and reporting platform. It allows medical professionals to exchange treatment outcome data for patients referenced to objective neurophysiology data obtained through a standard electroencephalogram (EEG). CNS Response connects mental health patients and their doctors with medication options that work based on the Company’s proprietary database of real-world patient outcomes.
The goal of PEER Online is to avoid trial and error pharmacotherapy, which is the main approach for treatment resistant patients. Based on CNS Response’s original physician-developed database, there are now over 37,350 outcomes for more than 9,900 unique patients in the PEER registry.
PEER Online allows physicians to compare and learn which medication treatments have been effective, and which have not been effective for their peers treating patients with similar brain patterns. It builds on CNS Response’s original physician-developed database, Referenced-EEG® (rEEG®). PEER unites crowdsourced data on physician outcomes with EEG, an accepted, well-normed test of brain function. PEER utilizes "machine learning" to improve as outcomes are added.
Yesterday, CNS Response announced that it applauds the 114th Congress for passing the Clay Hunt Suicide Prevention for American Veterans Act. This is an important step forward for independent oversight and evidence-based medicine. CNS Response said it is proud to have supported the Clay Hunt SAV Act with testimony submitted to Congress. The Company thanks the many veterans and mental health advocacy groups. These include Iraq and Afghanistan Veterans of America, Veterans of Foreign Wars, the American Psychiatric Association, and family members like Susan Selke who made the February 3, 2015 passage possible.
CNS Response, Inc. (CNSO), closed Wednesday's trading session at $0.21, even for the day, on 3,444 volume with 3 trades. The average volume for the last 60 days is 15,019 and the stock's 52-week low/high is $0.12/$0.719.
Resort Savers, Inc. (RSSV)
The QualityStocks Daily Newsletter would like to spotlight Resort Savers, Inc. (RSSV). Today, Resort Savers, Inc. closed trading at $0.45, even for the day. The stock’s average daily volume over the past 60 days is 13,758, and its 52-week low/high is $0.20/$0.45.
Resort Savers, Inc. announced today that it has closed a $700,000 investment in Worx America, Inc. The deal gives RSSV exclusive China rights for Worx America's proprietary environmental engineering technologies and a 20% pre-IPO equity option. In addition, the late stage investment will support the commercial development of new Worx patented technologies, which RSSV will have exclusive China rights to.
Resort Savers, Inc. (RSSV) has built its reputation as an innovative environmental energy engineering company with expert diagnostic abilities and a diversified line of patented products. The company’s acquisition model seeks to identify innovative and market-ready petroleum industry technologies for installation and distribution throughout the Greater China market.
RSSV also has exclusive China rights for Worx America’s proprietary environmental engineering technologies as well as a 20% pre-IPO equity option. The Worx automated robotic systems quickly clean oil tanks and recover clean oil from waste sludge, resulting in increased sales and cost savings. The Worx multiple line of products and services give RSSV the capacity to offer proprietary solutions for onshore, offshore and subsea oil production, refining, cleaning and reclamation.
RSSV’s goal is to rapidly gain market share in China’s under-served oil tank cleaning and sludge processing industries through Worx technologies and on-ground training and installation. Senior management of Worx has been working in the field at RSSV’s China operations and has developed a training program for top engineers to go to Houston for further training and on-site systems installation and operations.
The company is led by a solid management team, owns a growing line of proprietary market-specific systems, and has positioned itself well as a high margin, competitive company. With a global focus, RSSV continues to pursue strategic partnerships and the licensing of key technologies for its extensive and growing customer base. Disclaimer
Resort Savers, Inc. Company Blog
Resort Savers, Inc. News:
Resort Savers, Inc. Closes $700,000 Investment in Worx America
Resort Savers, Inc. Announces $2 Million Investment to Acquire Worx America, Inc. Interest
Resort Savers, Inc. (RSSV) is “One to Watch”
Cleartronic, Inc. (CLRI)
The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.095, up 46.15%, on 865 volume with 2 trades. The stock’s average daily volume over the past 60 days is 1,874, and its 52-week low/high is $0.04/$0.5499.
Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.
VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.
A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.
Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer
Cleartronic, Inc. Company Blog
Cleartronic, Inc. News:
Cleartronic Appoints Two New Members to Board of Directors
Cleartronic, Inc. (CLRI) Announces Capitalization Benefit Plan and Expansion of Board of Directors
Cleartronic Announces License Agreement With Collabria LLC
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.30, up 42.86%, on 1,500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,036 and its 52-week low/high is $0.06/$0.60.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
Dominovas Energy Corp. Appoints International Business Professional to Board of Directors
Dominovas Energy and Delphi Sign MOU
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0044, up 18.92%, on 3,938,909 volume with 51 trades. The stock’s average daily volume over the past 60 days is 3,944,404, and its 52-week low/high is $0.0008/$0.2998.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
As Prettie Girls! Customer Base Grows, the One World Doll Project Begins Product Line Expansion
Vivica A. Fox Talks About Her Collaboration With The One World Doll Project
The One World Doll Project to Release Collectors Doll With Vivica A. Fox
IFAN Financial, Inc. (IFAN)
The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.52, up 7.22%, on 111,255 volume with 66 trades. The stock’s average daily volume over the past 60 days is 714,631, and its 52-week low/high is $0.0114/$1.01.
IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.
Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.
Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.
IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer
IFAN Financial, Inc. Company Blog
IFAN Financial, Inc. News:
IFAN Financial, Inc. Announces the Launch of New Website and Investor Relations Kit
IFAN Financial Enters Agreement to Provide Development Assistance to Card Collaborative International, LLC
IFAN Financial Announces $1 Million Private Placement
Sparta Commercial Services, Inc. (SRCO)
The QualityStocks Daily Newsletter would like to spotlight Sparta Commercial Services, Inc. (SRCO). Today, Sparta Commercial Services, Inc. closed trading at $0.13, up 8.33%, on 24,403 volume with 1 trade. The stock’s average daily volume over the past 60 days is 56,670, and its 52-week low/high is $0.11/$1.34.
Sparta Commercial Services, Inc. (SRCO) is a New York-based technology company whose subsidiary, Specialty Reports, Inc., is a leader in developing, managing, and servicing custom mobile apps for small and medium sized businesses as well as for retail vehicle dealers, in addition to providing motor vehicle title history reports to dealers, insurance companies, financial institutions, consumers, and other interested parties. Sparta Commercial Services also offers and administers vehicle and capital equipment lease financing programs for municipalities.
iMobileApp.com develops and services customized mobile applications for powersports, automobile, recreation vehicle, marine, and agriculture equipment dealers as well as for racetracks, restaurants, liquor stores, schools and any other small to medium sized company. The iMobileApp allows businesses to stay in touch with their customers, to notify them of upcoming and ongoing promotions, special events, and provide them with the ability to view new and used inventory, communicate directly with the service department, and more. The mobile application is generated, packaged, and made available on-line, at no cost to the company's customers, through the Apple App Store and the Google Play Store.
The company also serves as a one-stop online source for various types of vehicle title history reports, including motorcycles, recreation vehicles, automobiles, light trucks, and commercial (heavy duty) trucks. Its online history report products include Cyclechex.com, a motorcycle vehicle title history report provider; RVchecks.com, a RV vehicle title history report provider; and CarVinReport.com, an automobile and light truck vehicle title history report provider, and TruckChex.com, a commercial (heavy duty) truck vehicle title history report provider.
In addition to consumers – both buyers and sellers – vehicle dealerships, insurance companies, financial institutions and others benefit from the information provided on these vehicle title history reports. The Specialty Reports, Inc. vehicle title history reports are featured online at NADAGuides.com, KBB.com and DMV.org, prominent online sources for pre-owned vehicle values and other important information for both buyers and sellers.
The company’s Municipal Lease Financing Program for local and/or state agencies throughout the country provides an economical way to finance essential equipment, from police motorcycles and cruisers to EMS equipment and busses, to virtually any type of equipment required. The lease purchase financing program receives considerable praise for its understanding of government acquisition procedures and its work with a wide range of vendors.
Sparta Commercial Services is an innovative and diversified company that has proven its ability to identify the needs and interests of its targeted markets, as well as develop products and services specifically designed to meet those needs and interests now and well into the future. With a full suite of offerings that address the challenges of the powersports, recreation, and auto industries, the company is well positioned to achieve strong future growth rates. Disclaimer
Sparta Commercial Services, Inc. Company Blog
Sparta Commercial Services, Inc. News:
Sparta Commercial Reports Continued Sales Growth
iMobileApp's Customer Base Continues to Grow and Broaden
Sparta Commercial Reports a Continuing Increase in Mobile App Sales
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0665, up 5.72%, on 1,746,023 volume with 155 trades. The stock’s average daily volume over the past 60 days is 568,866, and its 52-week low/high is $0.0555/$0.255.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial
International Stem Cell Corporation to Conduct Parkinson's Disease Clinical Study in Australia
International Stem Cell Corporation to Present at Biotech Showcase(TM) 2015
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Cleartronic, Inc. (CLRI) Appoints Two New Members to Board of Directors
- Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- Falcon Crest Energy (FCEN) Optimistic About Prospecting in Powder River Basin
- IFAN Financial, Inc. (IFAN) Announces the Launch of New Website and Investor Relations Kit
- International Stem Cell Corp. (ISCO) Announces Completion of Cell Bank for Parkinson's Disease Clinical Trial
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Purchases Majority of North American Shopping Network From Domark International
- One World Holdings, Inc. (OWOO) As Prettie Girls! Customer Base Grows, the One World Doll Project Begins Product Line Expansion
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Pure Hospitality Solutions, Inc. (PNOW) Expands Oveedia, Aligns With Sabre Travel Network
- Resort Savers, Inc. (RSSV) Closes $700,000 Investment in Worx America
- Save The World Air, Inc. (ZERO) Announces Engagement of QualityStocks Investor Relations Services
- Sibling Group Holdings, Inc. (SIBE) Interviewed by TheStockRadio.com
- Sparta Commercial Services, Inc. (SRCO) Reports Continued Sales Growth
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) Inks Deal to Monetize Intellectual Property for General Electric (GE)
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial